GB0225736D0 - T-Cell Independent Vaccine - Google Patents
T-Cell Independent VaccineInfo
- Publication number
- GB0225736D0 GB0225736D0 GB0225736A GB0225736A GB0225736D0 GB 0225736 D0 GB0225736 D0 GB 0225736D0 GB 0225736 A GB0225736 A GB 0225736A GB 0225736 A GB0225736 A GB 0225736A GB 0225736 D0 GB0225736 D0 GB 0225736D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cell independent
- independent vaccine
- vaccine
- cell
- independent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0225736A GB0225736D0 (en) | 2002-11-05 | 2002-11-05 | T-Cell Independent Vaccine |
PCT/GB2003/004738 WO2004041866A1 (en) | 2002-11-05 | 2003-11-03 | Conjugate composition comprising antibodies against cd40 or cd28 |
AU2003285483A AU2003285483A1 (en) | 2002-11-05 | 2003-11-03 | Conjugate composition comprising antibodies against cd40 or cd28 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0225736A GB0225736D0 (en) | 2002-11-05 | 2002-11-05 | T-Cell Independent Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0225736D0 true GB0225736D0 (en) | 2002-12-11 |
Family
ID=9947207
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0225736A Ceased GB0225736D0 (en) | 2002-11-05 | 2002-11-05 | T-Cell Independent Vaccine |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003285483A1 (en) |
GB (1) | GB0225736D0 (en) |
WO (1) | WO2004041866A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE537813T1 (en) * | 2005-09-30 | 2012-01-15 | Lipoxen Technologies Ltd | LIPOSOMAL VACCINE COMPOSITION OF A POLYSACCHARIDE ANTIGEN AND A PROTEIN ADJUVANT |
US20110189208A1 (en) * | 2008-09-24 | 2011-08-04 | Andrew William Heath | Tb vaccine |
WO2011158019A1 (en) | 2010-06-16 | 2011-12-22 | Adjuvantix Limited | Polypeptide vaccine |
WO2020257317A1 (en) * | 2019-06-18 | 2020-12-24 | Citranvi Biosciences, Llc | Rationally engineered carrier proteins for vaccines |
WO2020257315A1 (en) * | 2019-06-18 | 2020-12-24 | Citranvi Biosciences, Llc | Multiple antigen protein displayed adjuvant systems |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ502437A (en) * | 1997-07-17 | 2001-11-30 | Baxter Healthcare Sa | Immunogenic conjugates comprising H. influenzae type b (Hib) polysaccharide-recombinant refolded meningococcal outer membrane protein (rPorB) conjugate |
AU6677000A (en) * | 1999-08-27 | 2001-03-26 | University Health Network | Method for activating cytotoxic t-lymphocytes (ctls) in vivo : composition comprising antibody anti cd40 (or cd40l or cd40 binding protein) and an antigen |
CA2399940A1 (en) * | 2000-04-13 | 2001-10-25 | The Rockefeller University | Enhancement of antibody-mediated immune responses |
-
2002
- 2002-11-05 GB GB0225736A patent/GB0225736D0/en not_active Ceased
-
2003
- 2003-11-03 WO PCT/GB2003/004738 patent/WO2004041866A1/en not_active Application Discontinuation
- 2003-11-03 AU AU2003285483A patent/AU2003285483A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004041866A1 (en) | 2004-05-21 |
AU2003285483A1 (en) | 2004-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0213622D0 (en) | Vaccine Corporation | |
GB0202901D0 (en) | Novel vaccine | |
GB0226722D0 (en) | Vaccine | |
GB0329146D0 (en) | Vaccine | |
GB0225788D0 (en) | Vaccine | |
GB0225786D0 (en) | Vaccine | |
GB0212046D0 (en) | Vaccines | |
GB0228715D0 (en) | Vaccine | |
GB0218921D0 (en) | Novel vaccine | |
GB0305794D0 (en) | Vaccine | |
GB0209878D0 (en) | Vaccine | |
GB0225736D0 (en) | T-Cell Independent Vaccine | |
PL376534A1 (en) | Vaccine | |
GB0305793D0 (en) | Vaccine | |
GB0212036D0 (en) | Vaccines | |
EP1487852A4 (en) | Anti-protozoal vaccine | |
GB0206595D0 (en) | Vaccine | |
IL156434A0 (en) | Vaccine | |
GB0226179D0 (en) | Vaccine | |
GB0223355D0 (en) | Vaccine | |
GB0227619D0 (en) | Vaccine | |
GB0213364D0 (en) | Vaccine | |
GB0229594D0 (en) | Vaccine | |
GB0230170D0 (en) | Vaccine | |
GB0225531D0 (en) | Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |